# URMC Related Haplo-identical Donor BMT

> **NCT02660281** · PHASE1 · COMPLETED · sponsor: **University of Rochester** · enrollment: 74 (actual)

## Conditions studied

- Hematological Disease
- Immune Deficiencies
- Solid Tumors
- Myelofibrosis
- Multiple Myeloma
- Lymphoma

## Interventions

- **RADIATION:** Total Body Irradiation 1200 cGy
- **DRUG:** Fludarabine
- **DRUG:** Pre-Stem Cell Infusion Cyclophosphamide
- **DRUG:** Pre-Stem Cell Infusion Mesna
- **DRUG:** Busulfan
- **DRUG:** Melphalan
- **PROCEDURE:** Stem Cell Infusion
- **DRUG:** Post-Stem Cell Infusion Cyclophosphamide
- **DRUG:** Post-Stem Cell Infusion Mesna
- **DRUG:** Thiotepa

## Key facts

- **NCT ID:** NCT02660281
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2019-10-28
- **Final completion:** 2021-01-07
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2021-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02660281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02660281, "URMC Related Haplo-identical Donor BMT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02660281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*